Provided by Tiger Trade Technology Pte. Ltd.

Medicus Pharma Ltd.

0.1614
-0.0090-5.28%
Post-market: 0.1607-0.0007-0.43%18:31 EDT
Volume:17.78M
Turnover:3.08M
Market Cap:10.20M
PE:-0.10
High:0.1724
Open:0.1718
Low:0.1570
Close:0.1704
52wk High:3.05
52wk Low:0.1512
Shares:63.18M
Float Shares:56.90M
Volume Ratio:0.63
T/O Rate:31.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6597
EPS(LYR):-2.7356
ROE:-7446.11%
ROA:-110.67%
PB:-5.78
PE(LYR):-0.06

Loading ...

Medicus Selects 200 Μg SkinJect Patch as Lead Dose in Final Phase 2 Skin Cancer Study Report

Reuters
·
Yesterday

Medicus Pharma Publishes Abridged Final Phase 2 Skinject® Clinical Study Report (CSR) Results Identifying 200 ΜG D-Mna Patch as the Lead Development Dose

THOMSON REUTERS
·
Yesterday

Analysts Are Bullish on These Healthcare Stocks: IDEAYA Biosciences (IDYA), Medicus Pharma Ltd (MDCX)

TIPRANKS
·
Sep 09

Medicus Pharma Sharpened Strategy Centers on Precision Oncology and Targeted Rare Disease Programs

TIPRANKS
·
Sep 08

Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company

THOMSON REUTERS
·
Sep 08

Medicus Pharma - Cd228v Established as Principal Strategic Priority for Medicus Pharma

THOMSON REUTERS
·
Sep 08

Medicus Pharma Pivots to Precision Oncology, Prioritizing Cd228v Melanoma Proof-of-Concept Study

Reuters
·
Sep 08

U.S. Stocks on the MOVE-Gold Miners, Polestar Automotive, Nvidia

Reuters
·
Sep 03

Medicus Pharma Shares Down 20.5% Premarket; Co, Pfizer Enter Licensing Deal for Experimental Cancer Therapy

THOMSON REUTERS
·
Sep 03

Medicus Pharma Secures Global Pfizer License for CD228V

TIPRANKS
·
Sep 03

Medicus Pharma Surges on Pfizer Licensing Deal for Experimental Cancer Therapy

Reuters
·
Sep 03

Medicus Pharma Signs Co-Development, Licensing Deal with Pfizer for Cd228v Antibody-Drug Conjugate

Reuters
·
Sep 03

Medicus Pharma - Pays Pfizer $12 Mln Upfront, $15 Mln Due on First Anniversary - SEC Filing

THOMSON REUTERS
·
Sep 03

Medicus Pharma - Pfizer Paid the Company a One-Time, Non-Refundable Payment of $2.0 Million

THOMSON REUTERS
·
Sep 03

Medicus Pharma - Enters Co-Development and License Agreement with Pfizer on Sept 2, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 03

Medicus Pharma Advances SkinJect and Teverelix Amid Financing Gains and Going-Concern Risk

TIPRANKS
·
Aug 13

Medicus Pharma Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Medicus Pharma Q2 EPS $(0.21) Misses $(0.13) Estimate

Benzinga Earnings
·
Aug 13

Medicus Pharma Q2 EPS USD -0.21

THOMSON REUTERS
·
Aug 13

Medicus Pharma Q2 Operating Expenses USD 11.5 Million

THOMSON REUTERS
·
Aug 13